Xiangyang Ge

发表

Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization

Bin Zhou, Zheng Zhang, Haiyan Wang, 2022, Journal of Clinical Virology.

Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron

Bin Zhou, Zheng Zhang, Haiyan Wang, 2022, Virology journal.

Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes

Zheng Zhang, Mingxia Zhang, Shuo Song, 2021, Virology Journal.

A key F27I substitution within HCDR1 facilitates the rapid maturation of P2C-1F11-like neutralizing antibodies in a SARS-CoV-2-infected donor

Bin Zhou, Zheng Zhang, Qing Fan, 2022, Cell Reports.

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies

Zheng Zhang, Haiyan Wang, Qing Fan, 2021, Cell discovery.

Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in mice

Wei-long Liu, Yangbo Fu, Zheng Zhang, 2022, Virology journal.

Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA.4/5/2.75 subvariants in BA.2 breakthrough infections

Zheng Zhang, Haiyan Wang, X. Liao, 2022, Nature Communications.

Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination

Bin Zhou, Zheng Zhang, Haiyan Wang, 2022, Emerging microbes & infections.

The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year

Bin Zhou, Zheng Zhang, Haiyan Wang, 2022, Emerging microbes & infections.

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Linqi Zhang, Jincun Zhao, Xinquan Wang, 2020, Nature.